Muscular Dystrophy - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 138 pages report, published by Global Markets Direct

Report ThumbnailMay-2017
Muscular Dystrophy - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy - Pipeline Review, H1 2017, provides an overview of the Muscular Dystrophy (Musculoskeletal Disorders) pipeline landscape.

Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually appear before age 6 and may appear as early as

Read More
  • List of Figures
  • Number of Products under Development for Muscular Dystrophy, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration, H1 20
Read More
  • List of Tables
  • Number of Products under Development for Muscular Dystrophy, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Products under Development by Companies, H1 2017
  • Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Products under Dev
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 4
  • Muscular Dystrophy - Overview 5
  • Muscular Dystrophy - Therapeutics Development 6
  • Muscular Dystrophy - Therapeutics Assessment 15
  • Muscular Dystrophy - Companies Involved in Therapeutics Development 25
  • Muscular Dystrophy - Drug Profiles 38
  • Muscular Dystrophy - Dormant Projects 116
  • Muscular Dystrophy - Discontinued Products 118
  • Muscular Dystrophy - Product Development Milestones 119
  • Appendix 131
Read More

Please select a license type

Share

Related Products

Global Markets DirectMuscular Dystrophy - Pipeline Review, H1 2017Product ThumbnailMuscular Dystrophy - Pipeline Review, H1 2017, Industry ReportProduct #: 797272
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved